{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:49:44Z","timestamp":1791492584072,"version":"4.3.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["ZYYCXTD-D-202402"],"award-info":[{"award-number":["ZYYCXTD-D-202402"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["Z221100007422121"],"award-info":[{"award-number":["Z221100007422121"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.semnephrol.2026.151716","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:56:16Z","timestamp":1791406576000},"page":"151716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Traditional Chinese and Western Medicine for Immunoglobulin A Nephropathy: Recent Advances and Future Directions"],"prefix":"10.1016","author":[{"given":"Ying","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semnephrol.2026.151716_bib0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","article-title":"The pathogenesis of IgA nephropathy and implications for treatment","volume":"21","author":"Cheung","year":"2025","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151716_bib0002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.semnephrol.2018.05.015","article-title":"Genetic determinants of IgA nephropathy: Eastern perspective","volume":"38","author":"Li","year":"2018","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151716_bib0003","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000484717","article-title":"Changes in the spectrum of kidney diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China","volume":"4","author":"Hou","year":"2018","journal-title":"Kidney Dis(Basel)"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151716_bib0004","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/ndt\/gfae252","article-title":"Long-term outcomes of IgA nephropathy in China","volume":"40","author":"Shen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"Pt 3","key":"10.1016\/j.semnephrol.2026.151716_bib0005","article-title":"Integrative multi-omics and network pharmacology reveal the mechanisms of Fangji Huangqi decoction in treating IgA nephropathy","volume":"337","author":"Liu","year":"2025","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151716_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.apsb.2023.11.006","article-title":"Traditional Chinese medicine for the treatment of immune-related nephropathy: a review","volume":"14","author":"Jiang","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151716_bib0007","article-title":"Immunoglobulin A nephropathy: molecular pathogenesis and targeted therapy","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm (2020)"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151716_bib0008","doi-asserted-by":"crossref","first-page":"195","DOI":"10.53469\/jcmp.2025.07(07).38","article-title":"Experience of traditional Chinese and Western medicine in the treatment of IgA nephropathy","volume":"7","author":"Chen","year":"2025","journal-title":"J Contemp Med Pract"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151716_bib0009","first-page":"583","article-title":"The practice guidelines for Western medical diagnosis and Chinese medical syndrome typing of IgA nephropathy","volume":"33","year":"2013","journal-title":"Chin J Integr Tradit West Med"},{"issue":"27","key":"10.1016\/j.semnephrol.2026.151716_bib0010","first-page":"3395","article-title":"Clinical, pathological and TCM syndromes of primary IgA nephropathy with malignant hypertension","volume":"25","author":"Ke","year":"2022","journal-title":"Chin Gen Pract"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0011","article-title":"Efficacy of traditional Chinese medicine versus angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and their combinations in the treatment of IgA nephropathy: a systematic review and network meta-analysis","volume":"15","author":"Ma","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0012","series-title":"Guidelines for Diagnosis and Management of Immunoglobulin A Nephropathy With Integrated Traditional Chinese and Western Medicine","year":"2023"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151716_bib0013","first-page":"197","article-title":"A multi-centeric epidemiological survey on TCM syndrome in 1016 patients with IgA nephropathy and analysis of its relevant factors","volume":"26","author":"Chen","year":"2006","journal-title":"Chin J Integr Tradit West Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151716_bib0014","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0046-8177(82)80221-9","article-title":"IgA nephropathy: morphologic predictors of progressive renal disease","volume":"13","author":"Lee","year":"1982","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151716_bib0015","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","year":"2009","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151716_bib0016","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151716_bib0017","first-page":"101","article-title":"Multicenter prospective study on relationship of TCM syndrome type and renal pathology in 286 patients with IgA nephropathy","volume":"24","author":"Chen","year":"2004","journal-title":"Chin J Integr Tradit West Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151716_bib0018","first-page":"137","article-title":"A study of relativity between TCM syndrome and clinic pathology on 1010 patients with IgA nephropathy","volume":"37","author":"Yao","year":"2008","journal-title":"J Med Res"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151716_bib0019","first-page":"135","article-title":"Classification of TCM syndromes of IgA nephropathy: factor analysis and clustering analysis","volume":"37","author":"Chen","year":"2014","journal-title":"J Beijing Univ Trad Chin Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151716_bib0020","first-page":"696","article-title":"Prospective study on relationship of deficiency syndrome classification in TCM and renal pathology of IgA nephropathy in 354 patients","volume":"15","author":"Wan","year":"2014","journal-title":"Chin J Integr Trad West Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151716_bib0021","first-page":"31","article-title":"Study on pathological indicators in TCM microcosmic syndrome differentiation in dampness-heat syndrome of IgA nephropathy","volume":"22","author":"Wang","year":"2015","journal-title":"Chin J Inf Tradit Chin Med"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151716_bib0022","first-page":"1044","article-title":"Correlation study on pathological characteristics of target organs and excess evil syndrome in IgA nephropathy","volume":"35","author":"Yang","year":"2015","journal-title":"Chin J Integr Tradit West Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151716_bib0023","first-page":"687","article-title":"Study on the relationship between blood stasis syndrome and clinical pathology in patients with IgA nephropathy","volume":"25","author":"Wei","year":"2005","journal-title":"Chin J Integr Tradit West Med"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151716_bib0024","first-page":"2050","article-title":"Effect of Tripterygium wilfordii multiglucoside on intestinal flora and immune function in IgA nephropathy rats based on C1GALT1\/Cosmc pathway","volume":"36","author":"Ren","year":"2020","journal-title":"Chin J Pathophysiol"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151716_bib0025","first-page":"979","article-title":"The effect of Tripterygium wilfordii glycoside on the expression of CD4+ CD25high regulatory T cells, Th1 and Th2 with IgA nephropathy","volume":"14","author":"Shen","year":"2013","journal-title":"Chin J Integr Trad West Nephrol"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0026","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2147\/DDDT.S449119","article-title":"Sinomenine hydrochloride protects IgA nephropathy through regulating cell growth and apoptosis of T and B lymphocytes","volume":"18","author":"Li","year":"2024","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.semnephrol.2026.151716_bib0027","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.intimp.2019.02.056","article-title":"Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats","volume":"70","author":"Bai","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115233","article-title":"The therapeutic effect of Shenhua tablet against mesangial cell proliferation and renal inflammation in mesangial proliferative glomerulonephritis","volume":"165","author":"He","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114459","article-title":"Oleanolic acid inhibits mesangial cell proliferation and inflammatory response in mesangial proliferative glomerulonephritis through IL-17\/ERK\/AKT pathway","volume":"152","author":"Pan","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.biopha.2018.02.127","article-title":"Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPAR\u03b3\/NF-\u03baB pathway","volume":"101","author":"Liu","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151716_bib0031","first-page":"2298","article-title":"The effect of Huangkui capsule combined with benazepril on chronic glomerulonephritis and serum inflammatory factors","volume":"15","author":"Li","year":"2020","journal-title":"World J Integr Tradit West Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151716_bib0032","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0253-7613.150319","article-title":"Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy","volume":"47","author":"Chen","year":"2015","journal-title":"Indian J Pharmacol"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151716_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077794","article-title":"Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-\u03baB\/NLRP3 pathway","volume":"8","author":"Hua","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151716_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116873","article-title":"Nephrokeli, a Chinese herbal formula, may improve IgA nephropathy through regulation of the sphingosine-1-phosphate pathway","volume":"10","author":"Zhong","year":"2015","journal-title":"PLoS One"},{"issue":"31","key":"10.1016\/j.semnephrol.2026.151716_bib0035","first-page":"38","article-title":"Renal protection effect of Kunxian capsule on rat with IgA nephropathy and its influence on mesangial cell proliferation","volume":"57","author":"Zeng","year":"2019","journal-title":"Chin Mod Doctor"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106125","article-title":"Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway","volume":"80","author":"Xia","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151716_bib0037","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1139\/O07-002","article-title":"Mechanism of saikosaponin-d in the regulation of rat mesangial cell proliferation and synthesis of extracellular matrix proteins","volume":"85","author":"Zu","year":"2007","journal-title":"Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151716_bib0038","first-page":"346","article-title":"Jixuecao (Herba Centellae Asiaticae) alleviates mesangial cell proliferation in IgA nephropathy by inducing mitofusin 2 expression","volume":"39","author":"Chen","year":"2019","journal-title":"J Tradit Chin Med"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114795","article-title":"Efficacy of modified Huangqi Chifeng decoction in alleviating renal fibrosis in rats with IgA nephropathy by inhibiting the TGF-\u03b21\/Smad3 signaling pathway through exosome regulation","volume":"285","author":"Zhao","year":"2022","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151716_bib0040","first-page":"2822","article-title":"Effects of compound Xiancao granules on the TGF-\u03b2\/Smads signaling pathway in rats with IgA nephropathy-related glomerulosclerosis","volume":"21","author":"Huang","year":"2010","journal-title":"Lishizhen Med Mater Med Res"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151716_bib0041","first-page":"969","article-title":"Study on the therapeutic mechanism of total flavonoids from Abelmoschus manihot on IgA nephropathy in rats based on the Notch signaling pathway","volume":"19","author":"Zhao","year":"2018","journal-title":"Chin J Integr Trad West Nephrol"},{"issue":"740","key":"10.1016\/j.semnephrol.2026.151716_bib0042","doi-asserted-by":"crossref","first-page":"eadl6149","DOI":"10.1126\/scitranslmed.adl6149","article-title":"The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis","volume":"16","author":"Gleeson","year":"2024","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151716_bib0043","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41581-024-00845-x","article-title":"Role of the gut microbiota in the pathogenesis of IgA nephropathy","volume":"20","author":"Carney","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151716_bib0044","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1016\/j.apsb.2024.06.002","article-title":"Abelmoschus manihot polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating Akkermansia muciniphila abundance","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157545","article-title":"Multidimensional immunomodulation by Abelmoschi Corolla polysaccharide: gut barrier restoration, microbiota remodelling, and systemic metabolic regulation","volume":"149","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151716_bib0046","first-page":"112","article-title":"Effects of Huangkui capsule on intestinal microecology and metabolite in treatment of IgAN","volume":"51","author":"Liu","year":"2024","journal-title":"Liaoning J Tradit Chin Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151716_bib0047","first-page":"14","article-title":"Clinical study on Huangkui capsule as an adjuvant therapy for IgA nephropathy based on intestinal metabolism","volume":"17","author":"Liu","year":"2025","journal-title":"Res Integr Tradit Chin West Med"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151716_bib0048","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1007\/s00210-023-02888-6","article-title":"Study on the mechanism of hirudin multi target delaying renal function decline in chronic kidney disease based on the \u201cgut-kidney axis\u201d theory","volume":"397","author":"Long","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117561","article-title":"Altered serum metabolic profile in patients with IgA nephropathy","volume":"549","author":"Dong","year":"2023","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151716_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108525","article-title":"Single-cell transcriptomics reveal immune mechanisms of the onset and progression of IgA nephropathy","volume":"33","author":"Zheng","year":"2020","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151716_bib0051","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173651","article-title":"Cross-species single-cell analysis uncovers the immunopathological mechanisms associated with IgA nephropathy progression","volume":"9","author":"Chen","year":"2024","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151716_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.105961","article-title":"Proteomic profiling of IgA nephropathy reveals distinct molecular prognostic subtypes","volume":"26","author":"Chen","year":"2023","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151716_bib0053","article-title":"An inflammatory cytokine signature predicts IgA nephropathy severity and progression","volume":"5","author":"Chen","year":"2024","journal-title":"MedComm (2020)"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151716_bib0054","article-title":"Leveraging network target theory for efficient prediction of drug-disease interactions: a transfer learning approach","volume":"12","author":"Liu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151716_bib0055","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.apsb.2025.12.030","article-title":"Revolutionizing drug discovery from natural products: the roles of artificial intelligence and multi-omics in accelerating innovation","volume":"16","author":"Wang","year":"2026","journal-title":"Acta Pharm Sin B"},{"issue":"15","key":"10.1016\/j.semnephrol.2026.151716_bib0056","first-page":"1899","article-title":"Clinical observation of Huangkui capsule combined with cyclophosphamide and prednisone in the treatment of IgA nephropathy with renal insufficiency","volume":"36","author":"Jiang","year":"2025","journal-title":"China Pharmacy"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151716_bib0057","first-page":"284","article-title":"Analysis of the efficacy of Huangkui capsules combined with mycophenolate mofetil in the treatment of IgA nephropathy","volume":"20","author":"Wang","year":"2025","journal-title":"Intern Med"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0058","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3020033","article-title":"Clinical efficacy of Huangkui capsule plus methylprednisolone for immunoglobulin A nephropathy and its effect on renal function and serum inflammatory factors","volume":"2023","author":"Yuan","year":"2023","journal-title":"Evid Based Complement Alternat Med"},{"issue":"13","key":"10.1016\/j.semnephrol.2026.151716_bib0059","first-page":"130","article-title":"Clinical value analysis of Huangkui capsule combined with prednisone in the treatment of IgA nephropathy","volume":"16","author":"Ma","year":"2022","journal-title":"Chin J Mod Drug Appl"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151716_bib0060","first-page":"230","article-title":"Effect of Huangkui capsule combined with mycophenolate mofetil on IgA nephropathy in children and its effect on levels of BUN and Scr","volume":"40","author":"Zheng","year":"2022","journal-title":"Chin Arch Tradit Chin Med"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151716_bib0061","first-page":"1099","article-title":"Clinical analysis of Huangkui capsule combined with irbesartan in the treatment of IgA nephropathy","volume":"22","author":"Zhang","year":"2021","journal-title":"Chin J Integr Trad West Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151716_bib0062","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.joim.2021.01.009","article-title":"Efficacy and safety of Shenyankangfu tablet, a Chinese patent medicine, for primary glomerulonephritis: a multicenter randomized controlled trial","volume":"19","author":"Wu","year":"2021","journal-title":"J Integr Med"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153231","article-title":"Efficacy and safety of Abelmoschus manihot for IgA nephropathy: a multicenter randomized clinical trial","volume":"76","author":"Li","year":"2020","journal-title":"Phytomedicine"},{"issue":"20","key":"10.1016\/j.semnephrol.2026.151716_bib0064","first-page":"3306","article-title":"Efficacy of Niaoduqing granules combined with mycophenolate mofetil in the treatment of children with IgA nephropathy and its influence on inflammatory oxidative factors and immune function","volume":"25","author":"Suo","year":"2025","journal-title":"Prog Mod Biomed"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151716_bib0065","first-page":"609","article-title":"Clinical study on the protective effect of Tripterygium glycosides combined with angiotensin-converting enzyme inhibitors on proteinuria and renal function in patients with IgA nephropathy","volume":"26","author":"Wei","year":"2025","journal-title":"Chin J Integr Trad West Nephrol"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0066","article-title":"Efficacy and safety of Kunxian in IgA nephropathy","volume":"16","author":"Yang","year":"2025","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151716_bib0067","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12882-022-02814-7","article-title":"Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy","volume":"23","author":"Le","year":"2022","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151716_bib0068","first-page":"411","article-title":"A network meta-analysis of Chinese patent medicines combined with glucocorticoids and\/or immunosuppressants for the treatment of high-risk IgA nephropathy","volume":"26","author":"Cheng","year":"2025","journal-title":"Chin J Integr Trad West Nephrol"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0069","article-title":"Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Li","year":"2025","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151716_bib0070","first-page":"3050","article-title":"Efficacy and safety of Zheng Qing Feng Tong Ning combined therapy in the treatment of IgA nephropathy: a meta-analysis","volume":"31","author":"Tang","year":"2020","journal-title":"Lishizhen Med Mater Med Res"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0071","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9730753","article-title":"The effectiveness and safety of Abelmoschus manihot in treating IgA nephropathy: a systematic review and meta-analysis","volume":"2022","author":"Jia","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"issue":"23","key":"10.1016\/j.semnephrol.2026.151716_bib0072","first-page":"8756","article-title":"A meta-analysis of effects and safety of Tripterygium wilfordii polyglycoside in the treatment of IgA nephropathy","volume":"26","author":"Wang","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151716_bib0073","first-page":"441","article-title":"A network meta-analysis of Tripterygium wilfordii polyglycosides tablet, ambrette capsule and RAS blocker in the treatment of IgA nephropathy","volume":"20","author":"Fang","year":"2020","journal-title":"J Clin Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151716_bib0074","first-page":"101","article-title":"Multicentered randomized controlled clinical trial on patients with IgA nephropathy of qi-yin deficiency syndrome type","volume":"27","author":"Chen","year":"2007","journal-title":"Chin J Integr Tradit West Med"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151716_bib0075","first-page":"802","article-title":"Clinical study on Shenyan Kangfu tablets combined with leflunomide for IgA nephropathy with urinary abnormality","volume":"9","author":"Xia","year":"2008","journal-title":"Chin J Integr Trad West Nephrol"},{"issue":"23","key":"10.1016\/j.semnephrol.2026.151716_bib0076","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13020-020-00404-z","article-title":"Systematic review and meta-analysis of Tripterygium wilfordii multiglucoside in the treatment of adult IgA nephropathy","volume":"17","author":"Wang","year":"2020","journal-title":"China Med Herald"},{"issue":"22","key":"10.1016\/j.semnephrol.2026.151716_bib0077","first-page":"1929","article-title":"Treatment of severe IgA nephropathy patients with liver and kidney yin deficiency syndrome by traditional Chinese medicine syndrome differentiation combinated with losartan potassium: a prospective and multicentered clinical study","volume":"60","author":"Wang","year":"2019","journal-title":"J Tradit Chin Med"},{"issue":"20","key":"10.1016\/j.semnephrol.2026.151716_bib0078","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.4103\/0366-6999.216407","article-title":"Efficacy and safety of Niaoduqing particles for delaying moderate-to-severe renal dysfunction: a randomized, double-blind, placebo-controlled, multicenter clinical study","volume":"130","author":"Zheng","year":"2017","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151716_bib0079","first-page":"261","article-title":"Clinical practice guidelines for the treatment of chronic kidney disease stage 3-5 (non-dialysis) with Chinese patent medicine (2020)","volume":"41","year":"2021","journal-title":"Chin J Integr Tradit West Med"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0080","series-title":"Guidelines for Diagnosis and Management of Chronic Renal Failure With Integrated Traditional Chinese and Western Medicine","year":"2023"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151716_bib0081","first-page":"95","article-title":"Clinical practice guidelines on the treatment of chronic kidney disease with Niaoduqing granules","volume":"26","year":"2025","journal-title":"Chin J Integr Trad West Nephrol"},{"key":"10.1016\/j.semnephrol.2026.151716_bib0082","unstructured":"A prospective, multicenter, randomized, double-blind controlled trial comparing the efficacy and safety of total saponins extracted from leaves of rehmannia(TSELR) in the treatment of IgA nephropathy in children.Chinese Clinical Trial Registry. ChiCTR2500103806. Registered 2025. https:\/\/www.chictr.org.cn\/showproj.html?proj=272942."},{"key":"10.1016\/j.semnephrol.2026.151716_bib0083","unstructured":"A multi-center clinical study of the staged pattern differentiation of Qinghua and stasis removal preparations for the treatment of IgA nephropathy. Chinese Clinical Trial Registry. ChiCTR2400094993. Registered 2024. https:\/\/www.chictr.org.cn\/showproj.html?proj=225906."},{"issue":"4S","key":"10.1016\/j.semnephrol.2026.151716_bib0084","first-page":"S1","article-title":"KDIGO 2025 clinical practice guideline for the management of immunoglobulin A nephropathy (IgAN) and immunoglobulin A vasculitis (IgAV)","volume":"108","year":"2025","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151716_bib0085","first-page":"918","article-title":"Clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)","volume":"64","year":"2025","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151716_bib0086","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929526000355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929526000355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:07:19Z","timestamp":1791490039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929526000355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":86,"alternative-id":["S0270929526000355"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2026.151716","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Traditional Chinese and Western Medicine for Immunoglobulin A Nephropathy: Recent Advances and Future Directions","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2026.151716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151716"}}